I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Hematology Market - A Prelude
Recent Market Activity
Increase in Blood Related Disorders Drives Hematology
Instruments and Reagents Demand
Prevalence of Blood Disorders: An Opportunity Indicator
Market Share of Leading Players
The US Leads the Market, Asia-Pacific Witnesses Fastest Growth
Major Drivers in a Gist
Major Market Restraints
Hematology Analyzers Lead the Instruments Market
Innovations in Hematology Analyzers Market
Hematology Flow Cytometry Market Heading for Major Gains
Coagulation Analyzers Market to Register Notable Value Gains
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Abbott Diagnostics, Inc. (USA)
Beckman Coulter, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Drucker Diagnostics (USA)
Horiba Ltd. (Japan)
Instrumentation Laboratory, Inc. (USA)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
Roche Diagnostics (Switzerland) AG (Switzerland)
Siemens Healthcare (Germany)
Merck KGaA, (Germany)
Stago (France)
Sysmex Corporation (Japan)
Sysmex America, Inc. (USA)
Tcoag Ireland Ltd. (Ireland)

3. MARKET TRENDS & DRIVERS
Key Factors Influencing Market Growth
Increasing Cases of Blood Clotting Disorders
Increasing Reliance on Point-of-Care Testing
Developments in PoC Coagulation Analyser Technology
Availability of Handheld, User-Friendly Options
Manufacturer Focus on New and More Functional Products
Regulatory Challenges Limit Adoption
Automation - A Growing Trend in Hematological Instruments
Technological Advancements Drive the Hematology Devices Market
Point-of-care (POC) Testing Gains Popularity
Increasing Use of Flow Cytometry in Hematology Analyzers
Microfluidics in Hematology Aid in Improved Assessment
Immunohematology Market on a Steady Growth Path
Sustained Growth in Blood Collection Favors Hematology
instruments and reagents Market
Blood Supply Shortage & Safety Concerns Bode Well for
Hematology instruments and reagents Market
Aging Global Population Drives Market Growth
Increasing Incidence of HIV-AIDS Drive Demand
Anemia in CKD and Cancer Patients: Opportunity for Hematology
Instruments and Reagents
Increasing Healthcare Spending in Emerging Markets:
Opportunities in Store
Trend towards Home Monitoring Helps Point-of-Care (POC)
Hematology Analyzers Market
Reagent Manufacturers Innovate to Meet Rising Demands in Market
Specific Reagents Fare Better than Standard Reagents in
Coagulation Testing
The Need for Cell Differential Count

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Hematology
Instruments and Reagents by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Hematology Instruments and
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Hematology Instruments
and Reagents by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Reagents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Hematology
Analyzers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Hematology Analyzers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Hematology Analyzers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Hematology
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Hematology Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Hematology Reagents by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Coagulation
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Coagulation Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Coagulation Reagents by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Flow Cytometry
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Flow Cytometry Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Flow Cytometry Reagents
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Hematology Flow
Cytometers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hematology Flow Cytometers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Hematology Flow
Cytometers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 25: World Current & Future Analysis for Coagulation
Analyzers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Coagulation Analyzers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Coagulation Analyzers
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Immuno-Hematology
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Immuno-Hematology Reagents
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Immuno-Hematology
Reagents by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 31: World Current & Future Analysis for Hematology Vials
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Hematology Vials by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Hematology Vials by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Slide Stainers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 35: World Historic Review for Slide Stainers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Slide Stainers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Other Product
Segments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 38: World Historic Review for Other Product Segments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 39: World 15-Year Perspective for Other Product Segments
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 40: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 41: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 42: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 43: World Current & Future Analysis for Diagnostic
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 44: World Historic Review for Diagnostic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 45: World 15-Year Perspective for Diagnostic Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 46: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 47: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 48: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 49: USA Current & Future Analysis for Hematology
Instruments and Reagents by Product Group - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 50: USA Historic Review for Hematology Instruments and
Reagents by Product Group - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 51: USA 15-Year Perspective for Hematology Instruments
and Reagents by Product Group - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2020 &
2027

Table 52: USA Current & Future Analysis for Hematology
Instruments and Reagents by Product Segment - Hematology
Analyzers, Hematology Reagents, Coagulation Reagents, Flow
Cytometry Reagents, Hematology Flow Cytometers, Coagulation
Analyzers, Immuno-Hematology Reagents, Hematology Vials, Slide
Stainers and Other Product Segments - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 53: USA Historic Review for Hematology Instruments and
Reagents by Product Segment - Hematology Analyzers, Hematology
Reagents, Coagulation Reagents, Flow Cytometry Reagents,
Hematology Flow Cytometers, Coagulation Analyzers,
Immuno-Hematology Reagents, Hematology Vials, Slide Stainers
and Other Product Segments Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 54: USA 15-Year Perspective for Hematology Instruments
and Reagents by Product Segment - Percentage Breakdown of Value
Sales for Hematology Analyzers, Hematology Reagents,
Coagulation Reagents, Flow Cytometry Reagents, Hematology Flow
Cytometers, Coagulation Analyzers, Immuno-Hematology Reagents,
Hematology Vials, Slide Stainers and Other Product Segments for
the Years 2012, 2020 & 2027

Table 55: USA Current & Future Analysis for Hematology
Instruments and Reagents by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 56: USA Historic Review for Hematology Instruments and
Reagents by End-Use - Hospitals, Diagnostic Laboratories and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 57: USA 15-Year Perspective for Hematology Instruments
and Reagents by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

CANADA
Table 58: Canada Current & Future Analysis for Hematology
Instruments and Reagents by Product Group - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 59: Canada Historic Review for Hematology Instruments and
Reagents by Product Group - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 60: Canada 15-Year Perspective for Hematology Instruments
and Reagents by Product Group - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2020 &
2027

Table 61: Canada Current & Future Analysis for Hematology
Instruments and Reagents by Product Segment - Hematology
Analyzers, Hematology Reagents, Coagulation Reagents, Flow
Cytometry Reagents, Hematology Flow Cytometers, Coagulation
Analyzers, Immuno-Hematology Reagents, Hematology Vials, Slide
Stainers and Other Product Segments - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 62: Canada Historic Review for Hematology Instruments and
Reagents by Product Segment - Hematology Analyzers, Hematology
Reagents, Coagulation Reagents, Flow Cytometry Reagents,
Hematology Flow Cytometers, Coagulation Analyzers,
Immuno-Hematology Reagents, Hematology Vials, Slide Stainers
and Other Product Segments Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 63: Canada 15-Year Perspective for Hematology Instruments
and Reagents by Product Segment - Percentage Breakdown of Value
Sales for Hematology Analyzers, Hematology Reagents,
Coagulation Reagents, Flow Cytometry Reagents, Hematology Flow
Cytometers, Coagulation Analyzers, Immuno-Hematology Reagents,
Hematology Vials, Slide Stainers and Other Product Segments for
the Years 2012, 2020 & 2027

Table 64: Canada Current & Future Analysis for Hematology
Instruments and Reagents by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 65: Canada Historic Review for Hematology Instruments and
Reagents by End-Use - Hospitals, Diagnostic Laboratories and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 66: Canada 15-Year Perspective for Hematology Instruments
and Reagents by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

JAPAN
Table 67: Japan Current & Future Analysis for Hematology
Instruments and Reagents by Product Group - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 68: Japan Historic Review for Hematology Instruments and
Reagents by Product Group - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 69: Japan 15-Year Perspective for Hematology Instruments
and Reagents by Product Group - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2020 &
2027

Table 70: Japan Current & Future Analysis for Hematology
Instruments and Reagents by Product Segment - Hematology
Analyzers, Hematology Reagents, Coagulation Reagents, Flow
Cytometry Reagents, Hematology Flow Cytometers, Coagulation
Analyzers, Immuno-Hematology Reagents, Hematology Vials, Slide
Stainers and Other Product Segments - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 71: Japan Historic Review for Hematology Instruments and
Reagents by Product Segment - Hematology Analyzers, Hematology
Reagents, Coagulation Reagents, Flow Cytometry Reagents,
Hematology Flow Cytometers, Coagulation Analyzers,
Immuno-Hematology Reagents, Hematology Vials, Slide Stainers
and Other Product Segments Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 72: Japan 15-Year Perspective for Hematology Instruments
and Reagents by Product Segment - Percentage Breakdown of Value
Sales for Hematology Analyzers, Hematology Reagents,
Coagulation Reagents, Flow Cytometry Reagents, Hematology Flow
Cytometers, Coagulation Analyzers, Immuno-Hematology Reagents,
Hematology Vials, Slide Stainers and Other Product Segments for
the Years 2012, 2020 & 2027

Table 73: Japan Current & Future Analysis for Hematology
Instruments and Reagents by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 74: Japan Historic Review for Hematology Instruments and
Reagents by End-Use - Hospitals, Diagnostic Laboratories and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: Japan 15-Year Perspective for Hematology Instruments
and Reagents by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

CHINA
Table 76: China Current & Future Analysis for Hematology
Instruments and Reagents by Product Group - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 77: China Historic Review for Hematology Instruments and
Reagents by Product Group - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: China 15-Year Perspective for Hematology Instruments
and Reagents by Product Group - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2020 &
2027

Table 79: China Current & Future Analysis for Hematology
Instruments and Reagents by Product Segment - Hematology
Analyzers, Hematology Reagents, Coagulation Reagents, Flow
Cytometry Reagents, Hematology Flow Cytometers, Coagulation
Analyzers, Immuno-Hematology Reagents, Hematology Vials, Slide
Stainers and Other Product Segments - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 80: China Historic Review for Hematology Instruments and
Reagents by Product Segment - Hematology Analyzers, Hematology
Reagents, Coagulation Reagents, Flow Cytometry Reagents,
Hematology Flow Cytometers, Coagulation Analyzers,
Immuno-Hematology Reagents, Hematology Vials, Slide Stainers
and Other Product Segments Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 81: China 15-Year Perspective for Hematology Instruments
and Reagents by Product Segment - Percentage Breakdown of Value
Sales for Hematology Analyzers, Hematology Reagents,
Coagulation Reagents, Flow Cytometry Reagents, Hematology Flow
Cytometers, Coagulation Analyzers, Immuno-Hematology Reagents,
Hematology Vials, Slide Stainers and Other Product Segments for
the Years 2012, 2020 & 2027

Table 82: China Current & Future Analysis for Hematology
Instruments and Reagents by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 83: China Historic Review for Hematology Instruments and
Reagents by End-Use - Hospitals, Diagnostic Laboratories and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 84: China 15-Year Perspective for Hematology Instruments
and Reagents by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories and Other End-Uses for
the Years 2012, 2020 & 2027

EUROPE
Table 85: Europe Current & Future Analysis for Hematology
Instruments and Reagents by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Hematology Instruments and
Reagents by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 87: Europe 15-Year Perspective for Hematology Instruments
and Reagents by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2020 & 2027

Table 88: Europe Current & Future Analysis for Hematology
Instruments and Reagents by Product Group - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 89: Europe Historic Review for Hematology Instruments and
Reagents by Product Group - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 90: Europe 15-Year Perspective for Hematology Instruments
and Reagents by Product Group - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2020 &
2027

Table 91: Europe Current & Future Analysis for Hematology
Instruments and Reagents by Product Segment - Hematology
Analyzers, Hematology Reagents, Coagulation Reagents, Flow
Cytometry Reagents, Hematology Flow Cytometers, Coagulation
Analyzers, Immuno-Hematology Reagents, Hematology Vials, Slide
Stainers and Other Product Segments - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 92: Europe Historic Review for Hematology Instruments and
Reagents by Product Segment - Hematology Analyzers, Hematology
Reagents, Coagulation Reagents, Flow Cytometry Reagents,
Hematology Flow Cytometers, Coagulation Analyzers,
Immuno-Hematology Reagents, Hematology Vials, Slide Stainers
and Other Product Segments Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 93: Europe 15-Year Perspective for Hematology Instruments
and Reagents by Product Segment - Percentage Breakdown of Value
Sales for Hematology Analyzers, Hematology Reagents,
Coagulation Reagents, Flow Cytometry Reagents, Hematology Flow
Cytometers, Coagulation Analyzers, Immuno-Hematology Reagents,
Hematology Vials, Slide Stainers and Other Product Segments for
the Years 2012, 2020 & 2027

Table 94: Europe Current & Future Analysis for Hematology
Instruments and Reagents by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 95: Europe Historic Review for Hematology Instruments and
Reagents by End-Use - Hospitals, Diagnostic Laboratories and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 96: Europe 15-Year Perspective for Hematology Instruments
and Reagents by End-Use - Percentage Breakdown of Value Sales
for Hospitals, Diagnostic Laboratories and Other End-Uses for
the Years